The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Open accessAbstract
BACKGROUND: Coronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in this clinical context. METHODS: Using an observational database from 169 hospitals in Asia, Europe, and North America, we evaluated the relationship of cardiovascular disease and drug therapy with in-hospital death among hospitalized patients with Covid-19 who were admitted between December 20, 2019, and March 15, 2020, and were recorded in the Surgical Outcomes Collaborative registry as having either died in the hospital or survived to discharge as of March 28, 2020. RESULTS: Of the 8910 patients with Covid-19 for whom discharge status was available at the time of the analysis, a total of 515 died in the hospital (5.8%) and 8395 survived to discharge. The factors we found to be independently associated with an increased risk of in-hospital death were an age greater than 65 years (mortality of 10.0%, vs. 4.9% among those ≤65 years of age; odds ratio, 1.93; 95% confidence interval [CI], 1.60 to 2.41), coronary artery disease (10.2%, vs. 5.2% among those without disease; odds ratio, 2.70; 95% CI, 2.08 to 3.51), heart failure (15.3%, vs. 5.6% among those without heart failure; odds ratio, 2.48; 95% CI, 1.62 to 3.79), cardiac arrhythmia (11.5%, vs. 5.6% among those without arrhythmia; odds ratio, 1.95; 95% CI, 1.33 to 2.86), chronic obstructive pulmonary disease (14.2%, vs. 5.6% among those without disease; odds ratio, 2.96; 95% CI, 2.00 to 4.40), and current smoking (9.4%, vs. 5.6% among former smokers or nonsmokers; odds ratio, 1.79; 95% CI, 1.29 to 2.47). No increased risk of in-hospital death was found to be associated with the use of ACE inhibitors (2.1% vs. 6.1%; odds ratio, 0.33; 95% CI, 0.20 to 0.54) or the use of ARBs (6.8% vs. 5.7%; odds ratio, 1.23; 95% CI, 0.87 to 1.74). CONCLUSIONS: Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increased risk of in-hospital death among patients hospitalized with Covid-19. Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death in this clinical context. (Funded by the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
Siddiqi, H. K., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.012 · Cited by 1,701
Self-citationFerrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Research works printed but not linked: 1
- 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
Cited by
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31180-6 · Cited by 1,200
Self-citationRetractedWhy does COVID-19 disproportionately affect older people?
Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020) · Aging · doi:10.18632/aging.103344 · Cited by 1,128
Dessie, Z. G., & Zewotir, T. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06536-3 · Cited by 875
Collider bias undermines our understanding of COVID-19 disease risk and severity
Griffith, G. J., Morris, T. T., Tudball, M. J., Herbert, A., Mancano, G., Pike, L., Sharp, G. C., Sterne, J., Palmer, T. M., Davey Smith, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19478-2 · Cited by 826
Izcovich, A., Ragusa, M. A., Tortosa, F., Lavena Marzio, M. A., Agnoletti, C., Bengolea, A., Ceirano, A., Espinosa, F., Saavedra, E., Sanguine, V., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241955 · Cited by 660
Baqui, P., Bica, I., Marra, V., Ercole, A., & van der Schaar, M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30285-0 · Cited by 629
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
Haendel, M. A., Chute, C. G., Bennett, T. D., Eichmann, D. A., Guinney, J., Kibbe, W. A., Payne, P. R. O., Pfaff, E. R., Robinson, P. N., Saltz, J. H., et al. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa196 · Cited by 553
The unique characteristics of COVID-19 coagulopathy
Iba, T., Levy, J. H., Connors, J. M., Warkentin, T. E., Thachil, J., & Levi, M. (2020) · Critical Care · doi:10.1186/s13054-020-03077-0 · Cited by 533
Ssentongo, P., Ssentongo, A. E., Heilbrunn, E. S., Ba, D. M., & Chinchilli, V. M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238215 · Cited by 532
Leveraging media and health communication strategies to overcome the COVID-19 infodemic
Mheidly, N., & Fares, J. (2020) · Journal of Public Health Policy · doi:10.1057/s41271-020-00247-w · Cited by 522
The impact of ethnicity on clinical outcomes in COVID-19: A systematic review
Pan, D., Sze, S., Minhas, J. S., Bangash, M. N., Pareek, N., Divall, P., Williams, C. M., Oggioni, M. R., Squire, I. B., Nellums, L. B., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100404 · Cited by 519
Biswas, M., Rahaman, S., Biswas, T. K., Haque, Z., & Ibrahim, B. (2021) · Intervirology · doi:10.1159/000512592 · Cited by 504
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2021225 · Cited by 463
Self-citationRetractedEvans, P. C., Rainger, G. E., Mason, J. C., Guzik, T. J., Osto, E., Stamataki, Z., Neil, D., Hoefer, I. E., Fragiadaki, M., Waltenberger, J., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa230 · Cited by 437
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 418
Causes of death and comorbidities in hospitalized patients with COVID-19
Elezkurtaj, S., Greuel, S., Ihlow, J., Michaelis, E. G., Bischoff, P., Kunze, C. A., Sinn, B. V., Gerhold, M., Hauptmann, K., Ingold-Heppner, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82862-5 · Cited by 413
Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Zanza, C., Romenskaya, T., Manetti, A., Franceschi, F., La Russa, R., Bertozzi, G., Maiese, A., Savioli, G., Volonnino, G., & Longhitano, Y. (2022) · Medicina · doi:10.3390/medicina58020144 · Cited by 381
Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients
Rastrelli, G., Di Stasi, V., Inglese, F., Beccaria, M., Garuti, M., Di Costanzo, D., Spreafico, F., Greco, G. F., Cervi, G., Pecoriello, A., et al. (2021) · Andrology · doi:10.1111/andr.12821 · Cited by 360
Hippisley-Cox, J., Young, D., Coupland, C., Channon, K. M., Tan, P. S., Harrison, D. A., Rowan, K., Aveyard, P., Pavord, I. D., & Watkinson, P. J. (2020) · Heart · doi:10.1136/heartjnl-2020-317393 · Cited by 351
Vuong, Q.-H., Le, T.-T., La, V.-P., Nguyen, H. T. T., Ho, M.-T., Van Khuc, Q., & Nguyen, M.-H. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01034-6 · Cited by 344
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Huertas, A., Montani, D., Savale, L., Pichon, J., Tu, L., Parent, F., Guignabert, C., & Humbert, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.01634-2020 · Cited by 340
Association of poor housing conditions with COVID-19 incidence and mortality across US counties
Ahmad, K., Erqou, S., Shah, N., Nazir, U., Morrison, A. R., Choudhary, G., & Wu, W.-C. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241327 · Cited by 328
Clinical features of COVID-19 mortality: development and validation of a clinical prediction model
Yadaw, A. S., Li, Y.-C., Bose, S., Iyengar, R., Bunyavanich, S., & Pandey, G. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30217-x · Cited by 308
Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review
Bavishi, C., Bonow, R. O., Trivedi, V., Abbott, J. D., Messerli, F. H., & Bhatt, D. L. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.05.013 · Cited by 298
Haitao, T., Vermunt, J. V., Abeykoon, J., Ghamrawi, R., Gunaratne, M., Jayachandran, M., Narang, K., Parashuram, S., Suvakov, S., & Garovic, V. D. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.024 · Cited by 297
Lai, P. H., Lancet, E. A., Weiden, M. D., Webber, M. P., Zeig-Owens, R., Hall, C. B., & Prezant, D. J. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.2488 · Cited by 291
Bramante, C. T., Ingraham, N. E., Murray, T. A., Marmor, S., Hovertsen, S., Gronski, J., McNeil, C., Feng, R., Guzman, G., Abdelwahab, N., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(20)30033-7 · Cited by 291
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 289
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
Ng, W. H., Tipih, T., Makoah, N. A., Vermeulen, J.-G., Goedhals, D., Sempa, J. B., Burt, F. J., Taylor, A., & Mahalingam, S. (2021) · mBio · doi:10.1128/mbio.03647-20 · Cited by 288
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
Yang, J. M., Koh, H. Y., Moon, S. Y., Yoo, I. K., Ha, E. K., You, S., Kim, S. Y., Yon, D. K., & Lee, S. W. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.008 · Cited by 285
Reilev, M., Kristensen, K. B., Pottegård, A., Lund, L. C., Hallas, J., Ernst, M. T., Christiansen, C. F., Sørensen, H. T., Johansen, N. B., Brun, N. C., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa140 · Cited by 271
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease
Berretta, A. A., Silveira, M. A. D., Cóndor Capcha, J. M., & De Jong, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110622 · Cited by 269
Moon, A. M., Webb, G. J., Aloman, C., Armstrong, M. J., Cargill, T., Dhanasekaran, R., Genescà, J., Gill, U. S., James, T. W., Jones, P. D., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.013 · Cited by 266
Bader, F., Manla, Y., Atallah, B., & Starling, R. C. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10008-2 · Cited by 259
Datta, P. K., Liu, F., Fischer, T., Rappaport, J., & Qin, X. (2020) · Theranostics · doi:10.7150/thno.48076 · Cited by 257
Brouwers, S., Sudano, I., Kokubo, Y., & Sulaica, E. M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00221-x · Cited by 257
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05275-1 · Cited by 251
Lazarus, J. V., Ratzan, S., Palayew, A., Billari, F. C., Binagwaho, A., Kimball, S., Larson, H. J., Melegaro, A., Rabin, K., White, T. M., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240011 · Cited by 232
Pablos, J. L., Galindo, M., Carmona, L., Lledó, A., Retuerto, M., Blanco, R., Gonzalez-Gay, M. A., Martinez-Lopez, D., Castrejón, I., Alvaro-Gracia, J. M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218296 · Cited by 238
Methodological quality of COVID-19 clinical research
Jung, R. G., Di Santo, P., Clifford, C., Prosperi-Porta, G., Skanes, S., Hung, A., Parlow, S., Visintini, S., Ramirez, F. D., Simard, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21220-5 · Cited by 189
Neurological manifestations and implications of COVID-19 pandemic
Tsivgoulis, G., Palaiodimou, L., Katsanos, A. H., Caso, V., Köhrmann, M., Molina, C., Cordonnier, C., Fischer, U., Kelly, P., Sharma, V. K., et al. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420932036 · Cited by 145
Thrombotic complications of COVID-19
Avila, J., Long, B., Holladay, D., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.065 · Cited by 143
A roadmap to using randomization in clinical trials
Berger, V. W., Bour, L. J., Carter, K., Chipman, J. J., Everett, C. C., Heussen, N., Hewitt, C., Hilgers, R.-D., Luo, Y. A., Renteria, J., et al. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01303-z · Cited by 135
“Recently, two top medical journals, the New England Journal of Medicine and the Lancet, retracted two COVID-19 studies that relied on observational registry data [5, 6].”
BackgroundKohane, I. S., Aronow, B. J., Avillach, P., Beaulieu-Jones, B. K., Bellazzi, R., Bradford, R. L., Brat, G. A., Cannataro, M., Cimino, J. J., García-Barrio, N., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/22219 · Cited by 113
Type 2 diabetes mellitus and COVID-19: a narrative review
Corrao, S., Pinelli, K., Vacca, M., Raspanti, M., & Argano, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.609470 · Cited by 97
Danchev, V., Min, Y., Borghi, J., Baiocchi, M., & Ioannidis, J. P. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.33972 · Cited by 94
Tuccori, M., Convertino, I., Ferraro, S., Cappello, E., Valdiserra, G., Focosi, D., & Blandizzi, C. (2020) · Drug Safety · doi:10.1007/s40264-020-00965-w · Cited by 80
The overall impact of COVID ‐19 on healthcare during the pandemic: A multidisciplinary point of view
Sabetkish, N., & Rahmani, A. (2021) · Health Science Reports · doi:10.1002/hsr2.386 · Cited by 68
Gobat, N., Slack, C., Hannah, S., Salzwedel, J., Bladon, G., Burgos, J. G., Purvis, B., Molony-Oates, B., Siegfried, N., Cheah, P. Y., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00521-7 · Cited by 61
Insight into the Evolving Role of PCSK9
Maligłówka, M., Kosowski, M., Hachuła, M., Cyrnek, M., Bułdak, Ł., Basiak, M., Bołdys, A., Machnik, G., Bułdak, R. J., & Okopień, B. (2022) · Metabolites · doi:10.3390/metabo12030256 · Cited by 41
SCOR: A secure international informatics infrastructure to investigate COVID-19
Raisaro, J. L., Marino, F., Troncoso-Pastoriza, J., Beau-Lejdstrom, R., Bellazzi, R., Murphy, R., Bernstam, E. V., Wang, H., Bucalo, M., Chen, Y., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa172 · Cited by 40
Pritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00307 · Cited by 32
Davis, M. G., Bobba, A., Chourasia, P., Gangu, K., Shuja, H., Dandachi, D., Farooq, A., Avula, S. R., Shekhar, R., & Sheikh, A. B. (2022) · Viruses · doi:10.3390/v14122791 · Cited by 25
Rinderknecht, M. D., & Klopfenstein, Y. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00482-9 · Cited by 23
Poor visibility of retracted articles: a problem that should no longer be ignored
Boudry, C., Howard, K., & Mouriaux, F. (2023) · BMJ · doi:10.1136/bmj-2022-072929 · Cited by 22
An analysis of retractions in neurosurgery and allied clinical and basic science specialties
Madhugiri, V. S., Nagella, A. B., & Uppar, A. M. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-020-04615-z · Cited by 19
Shahbazi, F., Karami, M., Mirzaei, M., & Mohammadi, Y. (2021) · Journal of Research in Health Sciences · doi:10.34172/jrhs.2021.47 · Cited by 6
Metadata
- Authors
- Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-06-18
- Volume
- 382
- Issue
- 25
- Pages
- e102-e102
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3023826646
- Cited by
- 1,428
- References
- 25
- FWCI
- 40.53
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.